Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
27.5M
-
Shares change
-
-434K
-
Total reported value, excl. options
-
$192M
-
Value change
-
-$3.34M
-
Number of buys
-
48
-
Number of sells
-
-46
-
Price
-
$6.98
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q3 2021
112 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q3 2021.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.5M shares
of 44.7M outstanding shares and own 61.47% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.74M shares), Portolan Capital Management, LLC (2.36M shares), DIMENSIONAL FUND ADVISORS LP (1.97M shares), ROYCE & ASSOCIATES LP (1.82M shares), VANGUARD GROUP INC (1.8M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (1.62M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.58M shares), ACADIAN ASSET MANAGEMENT LLC (1.14M shares), RENAISSANCE TECHNOLOGIES LLC (1.08M shares), and Harvey Partners, LLC (1.02M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.